HERON THERAPEUTICS, INC. /DE/ Property, Plant and Equipment
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Property, Plant and Equipment of $11.81 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-10
- 2026-06-30: Property, Plant and Equipment, Net $11.81M.
- 2026-03-31: Property, Plant and Equipment, Net $12.03M.
- 2025-12-31: Property, Plant and Equipment, Net $12.40M.
- 2025-09-30: Property, Plant and Equipment, Net $12.96M.
| Period end | Property, Plant and Equipment, Net |
|---|---|
| 2026-06-30 | $11.81M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $12.03M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $12.40M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $12.96M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $13.68M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $14.54M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $14.86M 10-K · filed 2026-02-26 |
| 2024-09-30 | $15.41M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $15.90M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $19.31M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $20.17M 10-K · filed 2025-02-27 |
| 2023-09-30 | $20.79M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $20.87M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $21.51M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $22.16M 10-K · filed 2024-03-12 |
| 2022-09-30 | $22.62M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $23.47M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $23.86M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $23.73M 10-K · filed 2023-03-29 |
| 2021-09-30 | $22.79M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $22.18M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $22.70M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $22.74M 10-K · filed 2022-02-28 |
| 2020-09-30 | $21.74M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $21.89M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $21.91M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $19.62M 10-K · filed 2021-02-24 |
| 2019-09-30 | $16.32M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $17.91M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $16.27M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $14.68M 10-K · filed 2020-03-02 |
| 2018-09-30 | $10.58M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $7.50M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $6.50M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $5.98M 10-K · filed 2019-02-22 |
| 2017-09-30 | $5.34M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $5.75M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $5.68M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $5.08M 10-K · filed 2018-02-27 |
| 2016-09-30 | $4.70M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $4.47M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $3.65M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $3.05M 10-K · filed 2017-02-23 |
| 2015-09-30 | $2.98M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $2.90M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $3.00M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $2.82M 10-K · filed 2016-02-19 |
| 2014-09-30 | $2.91M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $2.98M 10-Q · filed 2014-08-04 |
| 2014-03-31 | $2.93M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $2.88M 10-K · filed 2015-03-13 |
| 2013-09-30 | $2.86M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $2.73M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $2.70M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $1.75M 10-K · filed 2014-03-07 |
| 2012-09-30 | $1.23M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $1.10M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $1.11M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $1.07M 10-K · filed 2013-03-01 |
| 2011-09-30 | $346.00K 10-Q · filed 2011-11-07 |
| 2011-06-30 | $263.00K 10-Q · filed 2011-08-08 |
| 2010-12-31 | $357.00K 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |